Lv41
506 积分 2026-05-13 加入
IL-15 as a key regulator in NK cell-mediated immunotherapy for cancer: From bench to bedside
3小时前
已完结
Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity
3小时前
已完结
Interleukin-2–based therapies in cancer
1个月前
已完结
Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis
1个月前
已完结
Safety of adoptive therapy with tumor-infiltrating lymphocytes and high-dose recombinant interleukin 2 in advanced cutaneous melanoma: a systematic review and meta-analysis
1个月前
已完结
Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries
1个月前
已完结
Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries
1个月前
已关闭
PD-1–targeted cis-delivery of an IL-2 variant induces a multifaceted antitumoral T cell response in human lung cancer
1个月前
已完结
PD-1–targeted cis-delivery of an IL-2 variant induces a multifaceted antitumoral T cell response in human lung cancer
1个月前
已完结
Role of cytokine-based immunotherapy approaches in gastrointestinal cancers
1个月前
已关闭
皖公网安备34019202002308
